{"id":"W2621569204","doi":"10.1200/jco.2017.35.15_suppl.1039","title":"Palbociclib (PAL) + letrozole (L) as first-line (1L) therapy (tx) in estrogen receptor-positive (ER+)/human epidermal growth factor receptor 2-negative (HER2−) advanced breast cancer (ABC): Efficacy and safety across patient (pt) subgroups.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Palbociclib; Internal medicine; Hazard ratio; Letrozole; Breast cancer; Population; Progression-free survival; Oncology; Metastatic breast cancer; Adverse effect; Cancer; Estrogen receptor; Gynecology; Tamoxifen; Confidence interval; Overall survival","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001659558,0.0005911313,0.002912602,0.0001511078,0.000589102,0.00006197654,0.000567164,0.0006949218,0.0008185481],"category_scores_gemma":[0.002953911,0.0004503429,0.0005912484,0.0001798253,0.001464466,0.0008126682,0.0002493896,0.002242932,0.00002751706],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001010867,"about_ca_system_score_gemma":0.0009978823,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007026301,"about_ca_topic_score_gemma":0.0007429938,"domain_scores_codex":[0.993628,0.0007300078,0.003325909,0.0007355045,0.0007006247,0.0008799851],"domain_scores_gemma":[0.9898938,0.002934581,0.004623383,0.0005899951,0.001107413,0.000850827],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0584864,0.002529165,0.2352221,0.00004894763,0.001104208,0.0003341991,0.002755466,0.00006495824,0.002778734,0.0001132743,0.0001600901,0.6964025],"study_design_scores_gemma":[0.04743824,0.01480126,0.9121369,0.0006934392,0.0001201846,0.0003865578,0.0006213062,0.00001492297,0.003437993,0.0005544699,0.01931052,0.0004842658],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.975585,0.001969914,0.00007804808,0.01931719,0.001468835,0.0009643887,0.0002893248,0.00003114521,0.0002961705],"genre_scores_gemma":[0.9854022,0.007611708,0.002431091,0.002408053,0.001855706,0.00005043988,0.00001804709,0.0000953416,0.0001274463],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6959182,"threshold_uncertainty_score":0.9997948,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05956333864583405,"score_gpt":0.4414005526879048,"score_spread":0.3818372140420708,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}